Clinical Trials Sponsored by Aspen Pharma

Total 8288 results

Aspen USA Inc

Withdrawn

A Randomized Controlled Phase 2 Study to Determine Lowest Efficacious Dose of Ovestin in Vulvar and Vaginal Atrophy (DOVE)

Vaginal Atrophy
Aspen Medical Products

Completed

Effectiveness of Inelastic LSO Versus Standard Medical Treatment for Back Pain Associated With Kyphosis (ARISE)

Back Pain | Kyphosis
Asten Sante
Slb Pharma; Withings; Nouvéal

Recruiting

Impact of Patient Involvement in Alerts Management of Telemonitoring CPAP

OSA

France
Aspen Global Incorporated

Terminated

Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban (HITSOVA)

Heparin-induced Thrombocytopenia

United States, Bosnia and Herzegovina, Canada, France, Germany, Italy, Poland, Russian Federation, Serbia
Aspen Global Incorporated

Completed

A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers.

Injection Site Reaction
Aspen Medical Products

Terminated

A Prospective, Multicenter, Randomized Control Study To Determine Clinical Effectiveness, Patient Wellness and Cost of Pain Related Care of In-Elastic Lumbar Sacral Orthoses Versus Standard Medical Treatment in Patients Presenting With Acute Low Back Pain In Primary Care Centers (The ARREST Study) (ARREST)

Back Pain | Low Back Pain
Aspen Medical Products

Completed

Efficacy of Peak Scoliosis Brace in Pain Management For Adult Scoliosis Patients

Back Pain
Asten Sante

Recruiting

Consequences of Respiratory Devices on Caregivers (CAP2) (CAP2)

Quality of Life

France
Pharmanex
Aspen Clinical Research

Completed

Effects of a Proprietary Blend of Herbal Extract Supplement on Cellular Detoxification, Inflammation, and Cumulative Cognitive Index as Well as Gene Expression in Middle-Aged Adult Women (Pharmanex)

Anti Aging

United States
Apsen Farmaceutica S.A.

Completed

Efficacy and Safety of S (+) - Ibuprofen in the Treatment of Mechanical Low Back Pain (APS002/2020)

Low Back Pain | Low Back Pain, Mechanical | Acute Low Back Pain

Brazil
Apsen Farmaceutica S.A.

Terminated

Phase III Efficacy and Tolerability Trial of the Fixed Dose Combination of Etodolac 400 mg and Cyclobenzaprine 10 mg Versus Isolated Active Substances in Pain Control After Impacted Third Molar Extraction (FDCETCB-III)

Pain, Acute

Brazil
Apsen Farmaceutica S.A.

Withdrawn

Efficacy And Safety Study Of Naftopidil to Patients Treatment With LUTS

Hyperplasia

Brazil
Apsen Farmaceutica S.A.

Recruiting

Efficacy and Safety of APSCTC for the Treatment of Postsurgical Pain Due to Third Molar Extraction (CARLOTA)

Postsurgical Pain | Third Molar Extraction

Brazil
Apsen Farmaceutica S.A.

Completed

Non Inferiority of Meclin® (Meclizine Chlorhydrate) Versus Dramin® (Dimenhydrinate) in Control of Acute Vertigo Symptoms From Peripheral Origin

Vertigo, Peripheral

Brazil
Apsen Farmaceutica S.A.

Withdrawn

Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere's Disease

Vertigo | Meniere Disease | Vertigo Vestibular
Apsen Farmaceutica S.A.

Completed

Phase I Study to Evaluate the Safety of Dexibuprofen 300mg Under Fasting and Fed Conditions

Healthy Volunteers

Brazil
Dallas VA Medical Center
Aspen Medical Products

Completed

Benefit of Lumbar Bracing for Chronic Low Back Pain Due to Degenerative Disc Disease

Low Back Pain | Degenerative Disc Disease | Lumbar Spondylosis
Texas Back Institute
Aspen Medical Products

Unknown

The Effect Spinal Bracing System on Gait in Adult Scoliosis Patients

Scoliosis

United States
University of Alberta
Aspen Medical Products

Completed

Effect of Lumbar Bracing on Spinal Function

Low Back Pain
Indiana University
ASPEN Rhoads Research Foundation

Terminated

Metabolic Response to Infliximab in Pediatric Ulcerative Colitis

Ulcerative Colitis | Energy Expenditure | Protein Metabolism

United States
Apsen Farmaceutica S.A.

Completed

Efficacy and Safety of S (+) - Ibuprofen in Osteoarthritis Pain (APS003/2020)

Osteoarthritis

Brazil
Apsen Farmaceutica S.A.

Completed

Phase I Study to Evaluate the Safety of Dexibuprofen 200mg Under Fasting and Fed Conditions

Healthy Volunteers

Brazil
Aspen Neuroscience
California Institute for Regenerative Medicine (CIRM)

Enrolling by invitation

Phase 1/2a Study of ANPD001 in Parkinson Disease (ASPIRO)

Parkinson Disease

United States
Massachusetts General Hospital
ASPEN Rhoads Research Foundation

Completed

Assessing Metabolic and Sleep Consequences of Overnight Home Parenteral Nutrition

Sleep | Glucose Intolerance | Short Bowel Syndrome | Feeding Patterns

United States
Fisher and Paykel Healthcare
Aspen Clinical Research

Completed

The Evaluation of the Toffee Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea

Obstructive Sleep Apnea

United States
Meander Medical Center
Wilhemina Ziekenhuis Assen

Unknown

Ergonomics of Laparoscopy: Robotic Camera Controlled Versus Human Camera Controlled

Ergonomics

Netherlands
Geoffrey C. Garth
VA Long Beach Healthcare System

Unknown

Chronic Opioid Use in Low Back Pain and Lumbar Orthosis Intervention

Chronic Lower Back Pain | Chronic Opioid Use

United States
R-Pharm
Covance; Cromos Pharma LLC

Withdrawn

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

COVID-19
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056

Rheumatoid Arthritis

United States, Belgium, United Kingdom
AJU Pharm Co., Ltd.
OM Pharma SA

Recruiting

The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Chronic Prostatitis | Chronic Pelvic Pain Syndrome

Korea, Republic of
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Japan, Korea, Republic of, Taiwan
Apsen Farmaceutica S.A.
Federal University of São Paulo

Withdrawn

Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)

Coronavirus Infections | SARS-CoV 2 | Pulmonary Disease | SARS (Severe Acute Respiratory Syndrome)

Brazil
Yuria-Pharm
Pharmaxi LLC

Completed

Epidemiological Study of the COVID-2019 in Participating Organizations.

Covid19

Ukraine
Centre Hospitalier Universitaire de Saint Etienne
Apsen Farmaceutica S.A.

Completed

Identification of Scores Associated With a Favorable Clinical Response With Thiopurines in IBD Patients (SCORE1)

Inflammatory Bowel Diseases

France
PT Sydna Farma
PT Pharma Metric Labs

Completed

Bioequivalence Study of Cyproterone Acetate and Ethinyl Estradiol in Healthy Female Volunteers

Drug Use

Indonesia
Monash University
Caring Pharmacy; Bionime Corporation; Tigas Pharma

Active, not recruiting

Prevention and Treatment of Diabetes in Adults

PreDiabetes

Malaysia
Mayo Clinic
St. Boniface Hospital; Lantheus Medical Imaging; The Asper Foundation

Completed

Early Detection of Broken Hearts in Cancer Patients (ASPER)

Cardiotoxicity

United States, Canada
University of Nottingham
Enhanced Recovery After Surgery Group (part of ESPEN)

Completed

Metabolic Response Following Intake of 2 Metabolic Preconditioning Drinks

Starvation

United Kingdom
Espen Lindholm
University College of Southeast Norway

Completed

Nurse Led Ultrasound Guided Femoral Nerve Block in the Emergency Department (URGENT)

Hip Fractures | Femoral Neck Fractures | Anesthesia

Norway
UCB Biopharma S.P.R.L.
Pharm Research Associates (UK) Ltd.

Completed

Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset Seizures (BASE)

Epilepsy With POS With or Without Secondary Generalization

Denmark, Germany, Hungary, Ireland, Italy, Netherlands, Norway, Spain, United Kingdom
UCB Pharma SA

Completed

Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy

Epilepsy

United States, Belgium, Czechia, France, Germany, Hungary, Ireland, Italy, Mexico, Poland, Spain, United Kingdom
UCB Pharma SA

Completed

Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam

Epilepsy, Partial

Canada, United States
Vifor Pharma, Inc.

Terminated

Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia (EMERALD)

Hyperkalemia

United States, Bulgaria, Canada, Georgia, Germany, Poland, Ukraine
UCB Pharma SA

Completed

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Epilepsy

Belgium, Finland, France, Germany, Hungary, India, Italy, Netherlands, Poland, Spain, Switzerland, United Kingdom
UCB Pharma SA

Completed

Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy

Generalized Epilepsy
UCB Pharma SA

Completed

Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)

Dermatitis, Atopic
UCB Pharma SA

Completed

A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] (PRECiSE 3)

Crohn's Disease

United States, Australia, Austria, Belarus, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, Israel, Italy, New Zealand, Norway, Poland, Russian Federation, Serbia, Singapore, Slovenia, South Africa, Spain, Ukraine, Canada and more
NicOx
Theradis pharma; Iris Pharma

Withdrawn

Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240) (Goldeneye)

Adenoviral Conjunctivitis

Spain
UCB Pharma GmbH

Completed

Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy (VICTOS)

Focal Epilepsy With and Without Secondary Generalization

Germany, Austria
UCB Pharma SA

Completed

Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults

Unverricht-Lundborg Disease

France, Italy, Sweden, Finland, Netherlands, Tunisia, Réunion

3

Subscribe